“Evaluation of quality of life in patients with gastric adenocarcinoma receiving chemoradiotherapy: a cross-sectional study”

[1] Bollschweiler E(2014)Treatment of early gastric cancer in the Western world World J Gastroenterol 20 5672-5678

[2] Berlth F(1982)Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy Int J Radiat Oncol Biol Phys 8 1-1377

[3] Baltin C(2003)Postoperative chemoradiotherapy for gastric cancer Ann Oncol 14 1373-3136

[4] Mönig S(2015)Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses J Clin Oncol 33 3130-84

[5] Hölscher AH(2010)Evaluating the impact on quality of life of chemoradiation in gastric cancer Curr Oncol 17 77-20

[6] Gunderson LL(2018)Assessment of quality of life in resectable gastric cancer patients undergoing chemoradiotherapy as adjuvant treatment South Asian J Cancer 7 16-178

[7] Sosin H(1998)Use of quality-of-life outcome assessments in current cancer clinical trials Eval Health Prof 21 157-2263

[8] Park SH(1995)The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy Eur J Cancer 31A 2260-1254

[9] Kim DY(1995)Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire J Clin Oncol 13 1249-104

[10] Heo JS(2008)Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients Eur J Cancer Care 17 98-2268

[1] Bollschweiler E(2014)Treatment of early gastric cancer in the Western world World J Gastroenterol 20 5672-5678

[2] Berlth F(1982)Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy Int J Radiat Oncol Biol Phys 8 1-1377

[3] Baltin C(2003)Postoperative chemoradiotherapy for gastric cancer Ann Oncol 14 1373-3136

[4] Mönig S(2015)Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses J Clin Oncol 33 3130-84

[5] Hölscher AH(2010)Evaluating the impact on quality of life of chemoradiation in gastric cancer Curr Oncol 17 77-20

[6] Gunderson LL(2018)Assessment of quality of life in resectable gastric cancer patients undergoing chemoradiotherapy as adjuvant treatment South Asian J Cancer 7 16-178

[7] Sosin H(1998)Use of quality-of-life outcome assessments in current cancer clinical trials Eval Health Prof 21 157-2263

[8] Park SH(1995)The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy Eur J Cancer 31A 2260-1254

[9] Kim DY(1995)Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire J Clin Oncol 13 1249-104

[10] Heo JS(2008)Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients Eur J Cancer Care 17 98-2268